About SOMAÍ
compassionate care scientifically crafted
At SOMAÍ, we are building a leading global brand with the most robust pipeline of innovative cannabis-based therapeutics. We envision a world where people live a healthy lifestyle empowered by natural cannabis medicine.
SOMAÍ owns a state-of-the-art manufacturing facility and indoor cultivation in Lisbon, Portugal, and has global sales teams in the largest medical cannabis markets. We are continuing to make acquisitions and global brand partnerships that make us one of a few and the first European-based vertically integrated companies in the EU able to cater to the diverse needs of fast-growing global cannabis markets.
Our Product Categories
For patients
FOR HEALTHCARE PROFESSIONALs
For partners
Company News
SOMAÍ Pharmaceuticals Announces Partnership with Releaf Clinic to Bring Innovative Cannabis Solutions to UK Patients
This collaboration marks the synergy of two vertically integrated fast-growing companies, combining SOMAÍ’s extensive cannabis extract portfolio with…
Read more
SOMAÍ Pharmaceuticals Launches in Ireland, Offering the Broadest Range of Cannabis-Based Medicines to Patients
SOMAÍ Pharmaceuticals Partners with Georgelle Pharmaceutical to Introduce Extensive Range of Cannabis-Based Medicines to Ireland
Read more
Cosma S.A. and SOMAÍ Pharmaceuticals partner to Revolutionize Poland with the most Innovative Cannabis-Based Solutions
Cosma S.A. and SOMAÍ Pharmaceuticals are thrilled to announce a strategic partnership that will introduce a range of…
Read more
SOMAÍ Pharmaceuticals Expands Its Most Comprehensive Medicinal Cannabis Portfolio With Launch of New Mint Oral Solutions Line
SOMAÍ Pharmaceuticals is proud to announce the Mint Oral Solutions product line launch in Australia, Germany, and the…
Read more
Leading Canadian Cannabis Brand Ghost Drops Enters into an Agreement with SOMAÍ Group for Global Distribution
The partnership opportunely positions Ghost Drops and SOMAÍ Group to succeed in the EU, UK, and Australian Cannabis…
Read more
SOMAÍ Group, and its subsidiary, RPK Biopharma expand Cookies partnership to include Europe and the UK
SOMAÍ Group and its subsidiary, RPK Biopharma expanded their existing partnership with Cookies to include additional territories for…
Read more
SOMAÍ Pharmaceuticals Introduces UK to The Most Complete Cannabis-Based Product Portfolio Following a Distribution Deal
SOMAÍ Pharmaceuticals signs distribution deal with Grow Pharma for UK’s most comprehensive range of cannabis-based medicines. This collaboration…
Read more
SOMAÍ Pharmaceuticals Acquires RPK Biopharma (Holigen), Reinforcing Global Leading Position in Medicinal Cannabis Sector
SOMAÍ Pharmaceuticals today announced it has entered into a definitive agreement with AKANDA Corp., an international medical cannabis…
Read more
SOMAÍ Pharmaceuticals Introducing the U.S. Award-Winning Airo Brand to European and Australian Markets
SOMAÍ Pharmaceuticals announces its partnership with AIRO BRANDS, a U.S. multi-state CPG company focused on proprietary cannabis products….
Read more
SOMAÍ Pharmaceuticals and Canify Announce Their Partnership to Introduce a Cannabinoid-Based Product Line in Germany
SOMAÍ Pharmaceuticals announces a landmark three-year marketing & distribution agreement with Canify AG. This partnership signifies SOMAÍ Pharmaceuticals’…
Read more
SOMAÍ Pharmaceuticals Enters German Market with Strategic Partnerships Securing €10 Million 2-year Distribution Deal
SOMAÍ Pharmaceuticals announces its entry into the German market through partnerships with Canymed GmbH and Grünhorn, securing a…
Read More
SOMAÍ Pharmaceuticals Partners with UK’s largest medical cannabis study T21 by Drug Science
SOMAÍ Pharmaceuticals is thrilled to announce partnering with the groundbreaking medical cannabis study, T21 (formerly Project TWENTY21). As…
read more
SOMAÍ Pharmaceuticals Signs Manufacturing Contract with Canna Forest
SOMAÍ Pharmaceuticals has signed a manufacturing agreement with Canna Forest to produce EU-GMP-certified extracted cannabis APIs and products…
read more
SOMAÍ Pharmaceuticals Receives EU-GMP Certification and Raises €5 million
SOMAÍ Pharmaceuticals Unipessoal LDA, the largest European pharmaceutical cannabis product manufacturer, is pleased to announce that it has…
Read more
SOMAÍ Pharmaceuticals has renewed the partnership with Lusófona University/CBIOS for formulation development
According to this partnership, Lusófona will develop lab-scale formulations and perform corresponding stability testing. The collaboration will also…
Read more
SOMAÍ Pharmaceuticals Signs Supply Contract with Cosma Cannabis
SOMAÍ Pharmaceuticals has entered into a two-year supply agreement with a well-respected Polish distributor Cosma Cannabis. Cosma produces…
Read more
Clever Leaves Partners with SOMAÍ Pharmaceuticals and Sends First Commercial Shipments to Portugal
SOMAÍ Pharmaceuticals Unipessoal LDA has entered into a five-year agreement with Clever Leaves Holdings Inc., a global medicinal…
Read more